These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 17189291

  • 1. Neuronal vulnerability of CLN3 deletion to calcium-induced cytotoxicity is mediated by calsenilin.
    Chang JW, Choi H, Kim HJ, Jo DG, Jeon YJ, Noh JY, Park WJ, Jung YK.
    Hum Mol Genet; 2007 Feb 01; 16(3):317-26. PubMed ID: 17189291
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium signaling.
    Lilliehook C, Chan S, Choi EK, Zaidi NF, Wasco W, Mattson MP, Buxbaum JD.
    Mol Cell Neurosci; 2002 Apr 01; 19(4):552-9. PubMed ID: 11988022
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Calsenilin and CALP interact with the cytoplasmic tail of UDP-Gal:GA2/GM2/GD2 beta-1,3-galactosyltransferase.
    Quintero CA, Valdez-Taubas J, Ferrari ML, Haedo SD, Maccioni HJ.
    Biochem J; 2008 May 15; 412(1):19-26. PubMed ID: 18269347
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Developmental impairments of select neurotransmitter systems in brains of Cln3(Deltaex7/8) knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis.
    Herrmann P, Druckrey-Fiskaaen C, Kouznetsova E, Heinitz K, Bigl M, Cotman SL, Schliebs R.
    J Neurosci Res; 2008 Jun 15; 86(8):1857-70. PubMed ID: 18265413
    [Abstract] [Full Text] [Related]

  • 10. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
    Narayan SB, Pastor JV, Mitchison HM, Bennett MJ.
    Brain; 2004 Aug 15; 127(Pt 8):1748-54. PubMed ID: 15240430
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
    Pohl S, Mitchison HM, Kohlschütter A, van Diggelen O, Braulke T, Storch S.
    J Neurochem; 2007 Dec 15; 103(6):2177-88. PubMed ID: 17868323
    [Abstract] [Full Text] [Related]

  • 12. Calsenilin is required for endocrine pancreas development in zebrafish.
    Stetsyuk V, Peers B, Mavropoulos A, Verbruggen V, Thisse B, Thisse C, Motte P, Duvillié B, Scharfmann R.
    Dev Dyn; 2007 Jun 15; 236(6):1517-25. PubMed ID: 17450605
    [Abstract] [Full Text] [Related]

  • 13. CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide.
    Puranam KL, Guo WX, Qian WH, Nikbakht K, Boustany RM.
    Mol Genet Metab; 1999 Apr 15; 66(4):294-308. PubMed ID: 10191118
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
    Kwon JM, Rothberg PG, Leman AR, Weimer JM, Mink JW, Pearce DA.
    Neurosci Lett; 2005 Oct 21; 387(2):111-4. PubMed ID: 16087292
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D, Pearce DA.
    Hum Mol Genet; 2005 Dec 01; 14(23):3759-73. PubMed ID: 16251196
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intracellular calcium modulates the nuclear translocation of calsenilin.
    Zaidi NF, Thomson EE, Choi EK, Buxbaum JD, Wasco W.
    J Neurochem; 2004 May 01; 89(3):593-601. PubMed ID: 15086516
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.